Useful links

Link	Useful for
International Society on Thrombosis and Haemostasis (ISTH)	Thrombosis and haemostasis; research; clinical trials outcomes; education.
Thrombosis and Haemostasis Society of Australia and New Zealand (THANZ)	Australia and New Zealand society for information on thrombosis and haemostasis.
Asian-Pacific Society on Thrombosis and Haemostatis (APSTH)	Thrombosis and haemostasis research in the Asian Pacific region.
Australian Haemophilia Centre Directors' Organisation (AHCDO)	Haemophilia - AHCDO is the national medical body for haemophilia in Australia.
Murdoch University	Research based tertiary institute degrees.
Clinicaltrials.gov	ClinicalTrials.gov is a database of privately and publicly funded clinical studies conducted around the world.
Cancer Council Western Australia	Specific focus on clinical trials offered within Western Australia.
ClinTrialRefer	App for connecting doctors, patients and clinical trial sites.
Australia New Zealand Clinical Trials Registry (ANZ CTR)	The ANZCTR is an online registry of clinical trials being undertaken in Australia, New Zealand and elsewhere.

Latest

Research Team Awarded DARF Dementia Grant

Perth Blood Institute is pleased to announce it is the recipient of the Norma Beaconsfield Project Grant, awarded by the Dementia Australia Research Foundation (DARF). This grant will allow the Platelet Research Team to continue important investigations into the effect of blood-thinning medication on dementia risk.
Covid-19 - Impact on blood transfusions and blood donations

Some members of the community may be concerned about the potential transmission of the COVID-19 virus through blood products, such as through blood transfusions. If you rely on blood products, you should feel confident to continue to receive them.
COVID-19

Perth Blood Institute takes the health of our staff, patients and supporters very seriously. We are responding to the COVID-19 situation and reviewing our protocols and responses daily. We thank all our stakeholders for working with us at this time. Cate Cassarchis, CEO
Investigating the effects of chronic Factor X anticoagulant exposure and dementia risk

This project aims to examine FXa inhibition on the risk of cognitive decline and investigates the molecular mechanisms underlying this association.

Accessibility
Privacy Policy

THE PERTH BLOOD INSTITUTE LIMITED ABN: 24164941815 (trading as Perth Blood Institute) takes your privacy seriously. We respect and uphold your right to privacy protection under the Australian Privacy Principles (APPs), by regulating the way in which we collect, use, disclose, hold and destroy your personal information. This Privacy Policy covers all personal information held by us.
Covid-19 - Impact on blood transfusions and blood donations

Some members of the community may be concerned about the potential transmission of the COVID-19 virus through blood products, such as through blood transfusions. If you rely on blood products, you should feel confident to continue to receive them.
Thomas' Story

Following months of consultations with various medical practitioners, Thomas was diagnosed with a cancerous growth in his lower back. Following this diagnosis and the development of a treatment plan, Thomas commenced a program of therapy under the care of Haematologist Professor Ross Baker.
Terms and Conditions
Research Team Awarded DARF Dementia Grant

Perth Blood Institute is pleased to announce it is the recipient of the Norma Beaconsfield Project Grant, awarded by the Dementia Australia Research Foundation (DARF). This grant will allow the Platelet Research Team to continue important investigations into the effect of blood-thinning medication on dementia risk.
Multiple Myeloma Clinical Trials Appeal

PBI is committed to developing new treatments for blood cancers and facilitates patient participation in clinical trials to access potentially lifesaving treatments not currently available elsewhere. Your support will enable us to participate in testing new treatment options to improve the health outcomes for patients with blood disorders, including multiple myeloma.
COVID-19

Perth Blood Institute takes the health of our staff, patients and supporters very seriously. We are responding to the COVID-19 situation and reviewing our protocols and responses daily. We thank all our stakeholders for working with us at this time. Cate Cassarchis, CEO
Inherited Thrombophilias

Information about genetic conditions that can increase the chances of thrombosis, including Factor V Leiden, Prothrombin 20210, and antithrombin, protein C, and protein S deficiency.
Travel & Thrombosis

Click here to learn about how travel can increase your risk of developing dangerous blood clots.

Perth Blood Institute

Your donation can help PBI to fund vital translational research into blood disorders including thrombosis and haemophilia; support a clinical research investigation into the development of a new treatment or intervention; or help us develop educational programs to foster the next generation of career haematologists. Read more

Donate Fundraise

Link

Useful for